
SEOUL: A South Korean company is looking for a business opportunity with partners from the Association of Southeast Asian Nations (Asean) to help develop the regional market for its Covid-19 vaccine.
"We are eyeing partners in the Asean market which has a combined population of more than 680 million," said Kim Young-suk, head of SK Bioscience's Strategy Department.